HARRISON THOMAS L

Director at ANTIGENICS INC /DE/ · on record since Apr 13, 2026
Director at Morgans Hotel Group Co. · on record since Feb 16, 2006
Chrmn/CEO Divers. Agency Serv. at OMNICOM GROUP INC · on record since Jul 2, 2008
Director at Atlin Mineral Exploration Corp. · on record since Aug 22, 2003
Director at EPOCRATES INC · on record since Feb 1, 2011
Director at Acurx Pharmaceuticals, Inc. · on record since Apr 22, 2026
Director at rVue Holdings, Inc. · on record since Dec 5, 2013
Director at Dipexium Pharmaceuticals, Inc. · on record since Mar 20, 2014
Director at Fifth Street Asset Management Inc. · on record since Oct 31, 2014
Director at Zynerba Pharmaceuticals, Inc. · on record since Aug 12, 2015
Director at Advanced Flower Capital Inc. · on record since Mar 25, 2021

Insider trading activity of HARRISON THOMAS L

Transactions on record: 91; since Aug 22, 2003

Open-market buys: 5; $466K

Open-market sells: 14; $3.2M

Companies traded: 11; last filing Aug 11, 2026

Figures computed from official regulatory filings — .

Companies where HARRISON THOMAS L has traded

ANTIGENICS INC /DE/10 tx · $172.1K · Aug 11, 2026
Acurx Pharmaceuticals, Inc.4 tx · Apr 22, 2026
Advanced Flower Capital Inc.7 tx · $155K · Nov 24, 2025
Zynerba Pharmaceuticals, Inc.8 tx · $208.7K · Jun 7, 2018
Fifth Street Asset Management Inc.13 tx · $420.3K · Dec 11, 2017
4 tx · $377.1K · Apr 20, 2017
2 tx · $70K · Dec 5, 2013
11 tx · $259.1K · Mar 13, 2013
6 tx · May 21, 2012
20 tx · $4.3M · Mar 31, 2010
6 tx · $613.3K · Apr 12, 2005

Track record of HARRISON THOMAS L

Statistical track record

Free

Open-market buys: 5

Last buy: Mar 23, 2021

Win rates and median returns are available with a free account (5 insiders/month).

Transaction history of HARRISON THOMAS L

Co-insiders of HARRISON THOMAS L

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
ANTIGENICS INC /DE/	Aug 11, 2026	AwardD (derivative)	50,000	0.00 USD	—	SEC
ANTIGENICS INC /DE/	Jul 7, 2026	Award	8,547	3.58 USD	$30.6K	SEC
ANTIGENICS INC /DE/	Apr 28, 2026	AwardD (derivative)	122,500	0.00 USD	—	SEC
Acurx Pharmaceuticals, Inc.	Apr 22, 2026	AwardD (derivative)	2,150	0.00 USD	—	SEC
ANTIGENICS INC /DE/	Apr 13, 2026	Award	9,228	3.32 USD	$30.6K	SEC
ANTIGENICS INC /DE/	Jan 5, 2026	Award	7,691	3.98 USD	$30.6K	SEC
Advanced Flower Capital Inc.	Nov 24, 2025	Award	5,474	2.74 USD	$15K	SEC
ANTIGENICS INC /DE/	Oct 3, 2025	Award	5,780	5.01 USD	$29K	SEC
ANTIGENICS INC /DE/	Jul 15, 2025	AwardD (derivative)	17,500	0.00 USD	—	SEC
ANTIGENICS INC /DE/	Jul 15, 2025	Award	7,401	3.46 USD	$25.6K	SEC
ANTIGENICS INC /DE/	Apr 3, 2025	Award	8,898	2.88 USD	$25.6K	SEC
Advanced Flower Capital Inc.	Feb 27, 2025	Award	1,792	8.37 USD	$15K	SEC
ANTIGENICS INC /DE/	Aug 8, 2024	AwardD (derivative)	7,500	0.00 USD	—	SEC
Acurx Pharmaceuticals, Inc.	Jun 18, 2024	AwardD (derivative)	12,000	0.00 USD	—	SEC
Advanced Flower Capital Inc.	Jan 25, 2024	Award	1,282	11.70 USD	$15K	SEC
Acurx Pharmaceuticals, Inc.	Jun 16, 2023	AwardD (derivative)	10,000	0.00 USD	—	SEC
Advanced Flower Capital Inc.	Jan 5, 2023	Award	963	15.57 USD	$15K	SEC
Advanced Flower Capital Inc.	Jan 13, 2022	AwardD (derivative)	5,000	0.00 USD	—	SEC
Acurx Pharmaceuticals, Inc.	Jul 6, 2021	AwardD (derivative)	50,000	0.00 USD	—	SEC
Advanced Flower Capital Inc.	Mar 25, 2021	AwardD (derivative)	700	0.00 USD	—	SEC
Advanced Flower Capital Inc.	Mar 25, 2021	Buy	5,000	19.00 USD	$95K	SEC
Zynerba Pharmaceuticals, Inc.	Jun 7, 2018	AwardD (derivative)	15,000	0.00 USD	—	SEC
Fifth Street Asset Management Inc.	Dec 11, 2017	Exercise	20,000	3.28 USD	$65.6K	SEC
Fifth Street Asset Management Inc.	Dec 11, 2017	Sell	-20,000	4.07 USD	$81.4K	SEC
Fifth Street Asset Management Inc.	Dec 11, 2017	Sell	-6,000	4.05 USD	$24.3K	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
ANTIGENICS INC /DE/	Aug 11, 2026	AwardD (derivative)	50,000	0.00 USD	—	SEC
ANTIGENICS INC /DE/	Jul 7, 2026	Award	8,547	3.58 USD	$30.6K	SEC
ANTIGENICS INC /DE/	Apr 28, 2026	AwardD (derivative)	122,500	0.00 USD	—	SEC
Acurx Pharmaceuticals, Inc.	Apr 22, 2026	AwardD (derivative)	2,150	0.00 USD	—	SEC
ANTIGENICS INC /DE/	Apr 13, 2026	Award	9,228	3.32 USD	$30.6K	SEC
ANTIGENICS INC /DE/	Jan 5, 2026	Award	7,691	3.98 USD	$30.6K	SEC
Advanced Flower Capital Inc.	Nov 24, 2025	Award	5,474	2.74 USD	$15K	SEC
ANTIGENICS INC /DE/	Oct 3, 2025	Award	5,780	5.01 USD	$29K	SEC
ANTIGENICS INC /DE/	Jul 15, 2025	AwardD (derivative)	17,500	0.00 USD	—	SEC
ANTIGENICS INC /DE/	Jul 15, 2025	Award	7,401	3.46 USD	$25.6K	SEC
ANTIGENICS INC /DE/	Apr 3, 2025	Award	8,898	2.88 USD	$25.6K	SEC
Advanced Flower Capital Inc.	Feb 27, 2025	Award	1,792	8.37 USD	$15K	SEC
ANTIGENICS INC /DE/	Aug 8, 2024	AwardD (derivative)	7,500	0.00 USD	—	SEC
Acurx Pharmaceuticals, Inc.	Jun 18, 2024	AwardD (derivative)	12,000	0.00 USD	—	SEC
Advanced Flower Capital Inc.	Jan 25, 2024	Award	1,282	11.70 USD	$15K	SEC
Acurx Pharmaceuticals, Inc.	Jun 16, 2023	AwardD (derivative)	10,000	0.00 USD	—	SEC
Advanced Flower Capital Inc.	Jan 5, 2023	Award	963	15.57 USD	$15K	SEC
Advanced Flower Capital Inc.	Jan 13, 2022	AwardD (derivative)	5,000	0.00 USD	—	SEC
Acurx Pharmaceuticals, Inc.	Jul 6, 2021	AwardD (derivative)	50,000	0.00 USD	—	SEC
Advanced Flower Capital Inc.	Mar 25, 2021	AwardD (derivative)	700	0.00 USD	—	SEC
Advanced Flower Capital Inc.	Mar 25, 2021	Buy	5,000	19.00 USD	$95K	SEC
Zynerba Pharmaceuticals, Inc.	Jun 7, 2018	AwardD (derivative)	15,000	0.00 USD	—	SEC
Fifth Street Asset Management Inc.	Dec 11, 2017	Exercise	20,000	3.28 USD	$65.6K	SEC
Fifth Street Asset Management Inc.	Dec 11, 2017	Sell	-20,000	4.07 USD	$81.4K	SEC
Fifth Street Asset Management Inc.	Dec 11, 2017	Sell	-6,000	4.05 USD	$24.3K	SEC